Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    22261812 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma
Condition: Melanoma
Interventions: Drug: sunitinib;   Drug: nivolumab
2 Completed Clinical Trial of Sutent to Treat Metastatic Melanoma
Condition: Metastatic Melanoma
Intervention: Drug: Sutent (sunitinib)

Study has passed its completion date and status has not been verified in more than two years.